STAODYN INC
8-K, 1996-05-31
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: ST JUDE MEDICAL INC, S-8, 1996-05-31
Next: SOUTHWEST CAPITAL CORP, 10QSB/A, 1996-05-31



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION

                            Washington, D.C.  20549

                                    FORM 8-K

                                 CURRENT REPORT



                     Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934



                          Date of Report: May 28, 1996



                                 STAODYN, INC.
- --------------------------------------------------------------------------------
             (Exact name of Registrant as specified in its charter)


        Delaware                    0-8350                 84-0684224
- --------------------------------------------------------------------------------
    (State or other              (Commission              (IRS Employer
    jurisdiction of              file number)          Identification No.)
    incorporation)


1225 Ken Pratt Boulevard, Longmont, Colorado                  80501
- --------------------------------------------------------------------------------
(Address of principal executive offices)                    (Zip Code)


                                    (303) 772-3631
- --------------------------------------------------------------------------------
             (Registrant's telephone number, including area code)



                                 Not Applicable
- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report)
<PAGE>
 
Item 5.  Other Events
- ---------------------

       On May 28, 1996, the Registrant announced that John R. South had been
elected President and Chief Executive Officer effective June 1, 1996.  A copy of
the Company's Press Release relating to this action is attached.

       W. Bayne Gibson, formerly Chairman, President and CEO of Staodyn, will
remain as Chairman of the Board.



                                   SIGNATURES

       Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                         STAODYN, INC.


                         By: /s/ MICHAEL J. NEWMAN
                             --------------------------------------
                             Michael J. Newman
                             Vice President - Finance & Administration



Dated:  May 28, 1996

<PAGE>
 
FOR RELEASE:   May 28, 1996


Contact:  Michael J. Newman
          Vice President - Finance
          (303) 772-3631

- -------------------------------------------------------------------------------

                          STAODYN NAMES JOHN R. SOUTH
                     PRESIDENT AND CHIEF EXECUTIVE OFFICER

LONGMONT, CO - Staodyn, Inc. (NASDAQ: SDYN) today announced that John R. South
had been elected President and Chief Executive Officer effective June 1, 1996.

Mr. South brings to Staodyn more than 25 years of general management and sales
and marketing experience.  He also has an extensive international background,
having resided and worked in Europe, Asia and Latin America.  Most recently, Mr.
South was President of the Medical & Diagnostic Business of Dynatech
Corporation, Burlington, Massachusetts.  Previously he held general and sales
management positions with SmithKline Beecham and Johnson & Johnson.  He holds an
M.B.A. from the Amos Tuck School of Dartmouth College, and a B.A. from Brown
University.

W. Bayne Gibson, formerly Chairman, President and CEO of Staodyn, will remain as
Chairman of the Board.

Staodyn is a leading developer and manufacturer of electromedical treatment
devices and accessories.  Its core business consists of medical electronic
products, primarily TENS (Transcutaneous Electrical Nerve Stimulation) devices
used for the relief of chronic and acute pain and NMES (Neuromuscular Electrical
Stimulation) devices used in physical therapy and sports medicine for muscle re-
education and rehabilitation.  The Company has also developed electrical
stimulation products for use in the treatment of severe skin wounds, and
currently markets these products in Canada and Europe.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission